A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Clinical trial NCT02087085 · TERMINATED

Trial details

NCT number: NCT02087085
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Geographic Atrophy Macular Degeneration

Start date: 2014-05-09
Primary completion: 2018-03-30
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.